What are the drugs for treating Helicobacter pylori

There are many drugs for treating Helicobacter pylori infection, most of which are antibiotics. Common drugs for treating Helicobacter pylori infection include tetracycline, metronidazole, furazolidone and amoxicillin. Currently, triple therapy is commonly used to treat Helicobacter pylori infection. This treatment method uses a variety of antibiotics in a rational combination to fight bacteria and treat the disease. Do not buy antibiotics casually to treat this disease.

The flagella of Helicobacter pylori are about 1 to 1.5 times longer than the bacterial body. The thickness is about 30nm. A ball-like object can sometimes be seen at the tip of the flagellum, which is actually an extension of the sheath. At the base of each flagellum, a spherical root can be seen extending into the inner side of the cell wall at the top of the bacterial body. There is also an area with reduced electron density inside it. Flagella act as propellers during movement and as anchors during settlement.

Helicobacter pylori is a microaerophilic bacterium that requires an environmental oxygen level of 5-8% and cannot survive in the atmosphere or in an absolutely anaerobic environment. Many solid culture media can be used as basic culture media for the isolation and culture of Helicobacter pylori. Brucella agar is used more frequently, but it requires the addition of an appropriate amount of whole blood or fetal bovine serum as a supplement in order to achieve growth. Vancomycin, TMP, amphotericin B and other antibacterial agents are often used to prevent the growth of bacteria.

Therefore, acute and chronic gastritis caused by HP infection. Diseases such as peptic ulcers may seem easy to treat, but in reality the results are not always ideal. Moreover, there is currently a lack of suitable animal models of HP infection to help develop effective treatment plans. Therefore, current treatment plans are almost entirely based on clinical experience and have great limitations (due to differences in regions and populations). In general, the use of a single antimicrobial drug is not recommended at present because its cure rate is low, generally <20%, and it is easy to develop drug resistance.

Triple therapy for the treatment of gastric diseases caused by Helicobacter pylori infection is recommended by the 9th World Congress of Gastroenterology and is also an effective treatment method. This treatment will combine seemingly unrelated antibiotics in a reasonable way and with a reasonable course of treatment, ultimately inhibiting Helicobacter pylori and completely eliminating the symptoms of gastritis, gastric ulcer, and duodenal ulcer caused by Helicobacter pylori infection.